Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 223-276-6 | CAS number: 3806-34-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 18 February 2013 to 05 March 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results. The study report was conclusive, done to a valid guideline and the study was conducted under GLP conditions.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories UK Ltd., Oxon., UK
- Age at study initiation: Eight to twelve weeks
- Weight at study initiation: 15 to 23 g
- Housing: Individually in suspended solid-floor polypropylene cages furnished with soft wood flakes
- Diet: ad libitum, 2014C Teklad Global Rodent diet (Harlan Laboratories UK Ltd., Oxon UK)
- Water: ad libitum, mains tap water
- Acclimation period: A minimum of five days
ENVIRONMENTAL CONDITIONS
- Temperature: 19 to 25°C
- Humidity: 30 to 70%
- Air changes: Approximately 15 changes per hour
- Photoperiod: 12 hours light/12 hours dark - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 2.5, 5 or 10% w/v in acetone/olive oil 4:1
- No. of animals per dose:
- 4 animals per dose
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: The vehicle was selected as it provided the highest concentration suitable for dosing
- Irritation: A preliminary screening test for toxicity and irritation was performed in one mouse prior to the main test. The mouse was treated by daily application (for three consecutive days) of the test material to the dorsal surface of each ear at a concentration of 10% w/v in acetone/olive oil 4:1 at a volume of 25 µL per ear. The mouse was observed twice daily on days 1, 2 and 3 and then once daily thereafter until day 6. Local skin irritation was scored daily as erythema. Any clinical signs of toxicity were also recorded. The thickness of each ear was measured using a Mitutoyo 547-300S digital thickness gauge pre-dose on day 1 post dose on day 3 and on day 6. Mean ear thickness was calculated between time days 1 and 3 and days 1 and 6. A mean ear thickness increase of 25% or more was considered to indicate excessive irritation and limited biological relevance to the determination of sensitisation. The preliminary test did not indicate any signs of local irritation or systemic toxicity of the test material, therefore 10% w/v in acetone/olive oil 4:1 was selected as the highest dose for the main test.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Animal assignment: Random
- Criteria used to consider a positive response: The test material would be considered a skin sensitiser if it produced in at least one concentration an increase of threefold or more of ³HTdR incorporation (Stimulation Index) compared to the control.
TREATMENT PREPARATION AND ADMINISTRATION:
25 µL of the test material in suspension was administered daily for three consecutive days to the dorsal surface of each ear at doses of 2.5, 5 or 10% w/v in acetone/corn oil 4:1. Four animals were treated per test material concentration, a further four animals were included as a vehicle control. Each treatment was spread evenly over the dorsal surface of each ear. Five days following the first topical application of the test material suspension, each mouse was administered 250 µL of ³H-methyl thymidine (80 µCi/mL, specific activity 2.0 Ci/mmol) in phosphate buffered saline intravenously via the tail vein, giving a total dose of 20 µCi per mouse. Five hours post administration of ³HTdR, the animals were sacrificed and the draining lymph nodes for all four mice per group were excised and pooled.
A single cell suspension of the pooled lymph nodes was prepared by gentle mechanical disaggregation using a 200-mesh stainless steel gauze. The lymph nodes were rinsed with 4 mL of phosphate buffered saline (PBS) into a petri dish. The lymph node suspension was then transferred into a centrifuge tube and the remaining lymph node cells were washed from the petri dish into the tube with an additional 5 mL of PBS. The suspension was centrifuged at 1400 rpm (approximately 190 g) for ten minutes. The pellet was resuspended in 10 mL PBS and re-pelleted. The pellet was then resuspended in 3 mL of 5% Trichloroacetic acid (TCA) to precipitate out the radioactive material.
After 18 hours of incubation at 4°C, the precipitates were recovered by centrifugation (2100 rpm, approximately 450 g for 10 minutes). The pellet was resuspended in 1 mL TCA and transferred to 10 mL of scintillation fluid. The vials containing the samples were placed in the sample changer of the scintillator and left for 20 minutes to reduce the risk of luminescence. Prior to counting the samples were shaken vigorously. The ³HTdR incorporation was measured by β-scintillation counting. The disintegrations per minute were measured using a Beckman LS6500 scintillation system. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- other: phenylacetaldehyde (CAS No 122-78-1) Tested at 2.5% in propylene glycol
- Parameter:
- SI
- Remarks on result:
- other: 2.5% w/w = 1.16 5% w/w = 1.58 10% w/w = 2.80
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Vehicle = 11110.37 dpm (1388.80 dpm/Node) 2.5% w/w = 12860.08 dpm (1607.51 dpm/Node) 5% w/w = 17532.82 dpm (2191.60 dpm/Node) 10% w/w = 31117.88 dpm (3889.74 dpm/Node)
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the test, the test material was found to be a non-sensitiser when applied to the skin of female CBA mice.
- Executive summary:
The study was performed to assess the skin sensitisation potential of the test material to female CBA mice following topical application to the dorsal surface of the ear. The study was GLP compliant and performed to the standardised guidelines OECD 429, EU Method B.42 and US EPA OPPTS 870.2600. The test material was screened for irritancy and systemic toxicity at 10% w/v in acetone/corn oil 4:1. This was selected as the highest dose tested in the main test. 25 µL of the test material in suspension was administered daily for three consecutive days to the dorsal surface of each ear at doses of 2.5, 5 or 10% w/v in acetone/corn oil 4:1. Four animals were treated per test material concentration, a further four animals were included as a vehicle control. Five days following the first topical application of the test material suspension, each mouse was administered 250 µL of ³H-methyl thymidine (80 µCi/mL, specific activity 2.0 Ci/mmol) in phosphate buffered saline intravenously via the tail vein, giving a total dose of 20 µCi per mouse. Five hours post administration of ³HTdR, the animals were sacrificed and the draining lymph nodes for all four mice per group were excised and pooled. The lymph nodes were prepared, and the ³HTdR incorporation was measured by β-scintillation counting. The scintillation index was calculated as the mean radioactive incorporation for each treatment group divided by the mean radioactivity incorporation of the vehicle control group. The stimulation indices of the test material at 2.5, 5 and 10% w/v in acetone/olive oil 4:1 were 1.16, 1.58 and 2.80 respectively. A stimulation index indicating a threefold increase of ³HTdR incorporation above the respective vehicle control was considered to be positive. Under the conditions of the test, the test material when tested up to 10 w/v in acetone/olive oil 4:1 was found to be a non-sensitser to the skin of CBA female mice.
Reference
Table 2: Clinical signs*, mortality and bodyweights
Concentration (% w/w) |
Animal Number |
Day 1 |
Day 2 |
Day 3 |
Day 4 |
Day 5 |
Day 6 |
Bodyweight Change (g) |
|||||
Mortality |
Bodyweight (g) |
Mortality |
Mortality |
||||||||||
A |
B |
A |
B |
A |
B |
Mortality |
Bodyweight (g) |
||||||
Vehicle |
1-1 |
0 |
0 |
21 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
22 |
1 |
1-2 |
0 |
0 |
21 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
20 |
-1 |
|
1-3 |
0 |
0 |
20 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
20 |
0 |
|
1-4 |
0 |
0 |
23 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
21 |
-2 |
|
2.5 |
2-1 |
0 |
0 |
23 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
21 |
-2 |
2-2 |
0 |
0 |
19 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
19 |
0 |
|
2-3 |
0 |
0 |
19 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
19 |
0 |
|
2-4 |
0 |
0 |
19 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
20 |
1 |
|
5 |
3-1 |
0 |
0 |
21 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
22 |
1 |
3-2 |
0 |
0 |
19 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
20 |
1 |
|
3-3 |
0 |
0 |
21 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
20 |
-1 |
|
3-4 |
0 |
0 |
19 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
20 |
1 |
|
10 |
4-1 |
0 |
0 |
19 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
20 |
1 |
4-2 |
0 |
0 |
18 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
20 |
2 |
|
4-3 |
0 |
0 |
23 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
23 |
0 |
|
4-4 |
0 |
0 |
21 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
21 |
0 |
|
A = Pre-dose B = Post dose * No symptoms of toxicity were observed during the test |
Table 3: Disintegrations per minute, disintegrations per minute/node and stimulation index
Concentration (% w/w) |
dpm |
dpm/Nodea |
Stimulation Indexb |
Result |
Vehicle |
11110.37 |
1388.80 |
na |
na |
2.5 |
12860.08 |
1607.51 |
1.16 |
Negative |
5 |
17532.82 |
2191.60 |
1.58 |
Negative |
10 |
31117.88 |
3889.74 |
2.80 |
Negative |
dpm = disintegrations per minute adisintegrations per minute/node obtained by dividing the disintegrations per minute value by 8 (total number of lymph nodes) bStimulation index of 3.0 or greater indicates a positive result na = not applicable |
Validation of the results:
The results of the study were compared to the responses of known sensitisers and non-sensitisers from the laboratory's in-house validation. The results of the routine positive control studies demonstrated that the stain of mouse used in the study from the performing laboratory produce satisfactory responses using known sensitisers and non-sensitiser. The results of the current study are therefore considered to be adequate for the prediction of the sensitising potential of the test material.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The key study was performed to assess the skin sensitisation potential of the test material to female CBA mice following topical application to the dorsal surface of the ear. The study was GLP compliant and performed to the standardised guidelines OECD 429, EU Method B.42 and US EPA OPPTS 870.2600. The test material was screened for irritancy and systemic toxicity at 10% w/v in acetone/corn oil 4:1. This was selected as the highest dose tested in the main test. 25 µL of the test material in suspension was administered daily for three consecutive days to the dorsal surface of each ear at doses of 2.5, 5 or 10% w/v in acetone/corn oil 4:1. Four animals were treated per test material concentration, a further four animals were included as a vehicle control. Five days following the first topical application of the test material suspension, each mouse was administered 250 µL of ³H-methyl thymidine (80 µCi/mL, specific activity 2.0 Ci/mmol) in phosphate buffered saline intravenously via the tail vein, giving a total dose of 20 µCi per mouse. Five hours post administration of ³HTdR, the animals were sacrificed and the draining lymph nodes for all four mice per group were excised and pooled. The lymph nodes were prepared, and the ³HTdR incorporation was measured by β-scintillation counting. The scintillation index was calculated as the mean radioactive incorporation for each treatment group divided by the mean radioactivity incorporation of the vehicle control group. The stimulation indices of the test material at 2.5, 5 and 10% w/v in acetone/olive oil 4:1 were 1.16, 1.58 and 2.80 respectively. A stimulation index indicating a threefold increase of ³HTdR incorporation above the respective vehicle control was considered to be positive. Under the conditions of the test, the test material when tested up to 10% w/v in acetone/olive oil 4:1 was found to be a non-sensitser to the skin of CBA female mice.
Migrated from Short description of key information:
Not sensitising; mouse; OECD 429, EU Method B.42 and US EPA OPPTS 870.2600 Henzell (2013)
Justification for selection of skin sensitisation endpoint:
Only one study was available. The study was performed to a high standard in line with GLP and to standardised guidelines, with a good level of reporting of the methodology and the results. The study was therefore assigned a reliability score of 1 in accordance with the principles for assessing data quality as defined in Klimisch (1997).
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
Based on the known properties of the test material, and the negative response observed in the skin sensitisation study, the test material is not anticipated to be a respiratory sensitiser.
Justification for classification or non-classification
In accordance with the criteria for classification as defined in Annex I, Regulation 1272/2008, the test material does not require classification for skin sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.